Surgerii Robotics has raised $100 million USD in a Series D funding round led by Loyal Valley Capital, with participation from Shanghai Healthcare Capital, V Star Capital, DNV Capital, and Hefei Industrial Investment. The company said in a LinkedIn post that the financing will be used to support international commercialization of its single-port surgical robot and to advance development of future products.
The China-based company develops robotic systems designed to perform minimally invasive procedures through a single incision. Its flagship platform, the SHURUI single-port surgical robot, received regulatory approval in China in 2023 and CE certification in 2025 for use across multiple surgical specialties in Europe. Surgerii said the system has been used in more than 3,000 procedures at over 70 hospitals.
Surgerii has also expanded its clinical footprint outside China, including the establishment of a European clinical center in partnership with IRCAD in 2025. The company said the latest funding strengthens its ability to scale manufacturing, clinical adoption, and regulatory efforts as it competes in the global surgical robotics market.
Image credit: Surgerii Robotics
